Gene · 1942
Papers1,708
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,708
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of the Tumor Microenvironment in Triple-Positive Breast Cancer Progression and Therapeutic Resistance. | Cancers (Basel) | 2023 | 38001753 | PubTator, text mining | PubMed |
| CDK5: an oncogene or an anti-oncogene: location location location. | Mol Cancer | 2023 | 37993880 | PubTator, text mining | PubMed |
| Mechanistic insights into the alterations and regulation of the AKT signaling pathway in diabetic retinopathy. | Cell Death Discov | 2023 | 37978169 | PubTator, text mining | PubMed |
| Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease. | J Am Coll Cardiol | 2023 | 37940228 | PubTator, text mining | PubMed |
| Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity. | J Chem Inf Model | 2023 | 37910792 | PubTator, text mining | PubMed |
| A Pharmacological Investigation of Eph-Ephrin Antagonism in Prostate Cancer: UniPR1331 Efficacy Evidence. | Pharmaceuticals (Basel) | 2023 | 37895923 | PubTator, text mining | PubMed |
| Multi-omics characteristics of tumor-associated macrophages in the tumor microenvironment of gastric cancer and their exploration of immunotherapy potential. | Sci Rep | 2023 | 37880233 | PubTator, text mining | PubMed |
| Genome-wide association study meta-analysis supports association between MUC1 and ectopic pregnancy. | Hum Reprod | 2023 | 37877466 | PubTator, text mining | PubMed |
| Actin cytoskeleton remodeling at the cancer cell side of the immunological synapse: good, bad, or both? | Front Immunol | 2023 | 37869010 | PubTator, text mining | PubMed |
| Recent Advances in Single-Cell RNA-Sequencing of Primary and Metastatic Clear Cell Renal Cell Carcinoma. | Cancers (Basel) | 2023 | 37835428 | PubTator, text mining | PubMed |
| Downregulation of EphA2 stability by RNF5 limits its tumor-suppressive function in HER2-negative breast cancers. | Cell Death Dis | 2023 | 37816703 | PubTator, text mining | PubMed |
| In-silico and structure-based assessment to evaluate pathogenicity of missense mutations associated with non-small cell lung cancer identified in the Eph-ephrin class of proteins. | Genomics Inform | 2023 | 37813626 | PubTator, text mining | PubMed |
| Meta-analysis of lean and obese RNA-seq datasets to identify genes targeting obesity. | Bioinformation | 2023 | 37808366 | PubTator, text mining | PubMed |
| Autocrine role of senescent cardiac fibroblasts-derived extracellular vesicles. | J Vet Med Sci | 2023 | 37779091 | PubTator, text mining | PubMed |
| Application of Protein-Protein Interaction Network Analysis in Order to Identify Cervical Cancer miRNA and mRNA Biomarkers. | ScientificWorldJournal | 2023 | 37746664 | PubTator, text mining | PubMed |
| Single-chain fragment antibody disrupting the EphA4 function as a therapeutic drug for gastric cancer. | Biochem Biophys Res Commun | 2023 | 37741263 | PubTator, text mining | PubMed |
| Utility of FRET in studies of membrane protein oligomerization: The concept of the effective dissociation constant. | Biophys J | 2023 | 37735871 | PubTator, text mining | PubMed |
| Proteomic architecture of frailty across the spectrum of cardiovascular disease. | Aging Cell | 2023 | 37731195 | PubTator, text mining | PubMed |
| Dysregulation of core neurodevelopmental pathways-a common feature of cancers with perineural invasion. | Front Genet | 2023 | 37719704 | PubTator, text mining | PubMed |
| Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19. | iScience | 2023 | 37664617 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1942/papers?page=6